The AAAAI Annual Meeting Program Committee oversees the development and confirmation of all educational sessions in the categories listed above. This process of development takes place throughout an eighteen month planning cycle. Although industry partners typically can have no input into the content of these educational sessions, the topics often coincide with the latest advances and breakthroughs in the specialty, and interest in supporting these educational sessions is high. In order to fairly and efficiently deal with multiple requests for support, the AAAAI will abide by the following processes and procedures in confirming support of these educational sessions
$25,000 Category |
Plenary
|
2101 |
Immunopathogenesis of Asthma |
3101 |
Presidential Plenary: Allergen Exposure and Chronic Allergic Disease |
4101 |
Understanding Asthma Risk Factors: Influence of Gender, Age and Obesity |
5101 |
Molecular Scalpels for Immune Modulation |
Keynote
|
2701 |
Emerging and Re-Emerging Infectious Diseases: The Perpetual Challenge to Global Health |
$20,000 Category
|
Symposia
|
2301 |
New Vaccines: Not Just For Children |
2302 |
Bench to Bedside: Atopic Dermatitis |
2303 |
Mast Cells: Pivotal Regulators of Host Defense |
2304 |
Non-Allergic Asthma: Searching for Causes? |
2305 |
Air Pollutants as Adjuvants in Allergic Diseases and Asthma: A New Era for the Allergy Specialty |
2306 |
Medical Informatics and the A/I Specialty |
2307 |
Allergies of The EYE in The Eyes of The Allergist |
3301 |
Are Current Clinical Tests for Airway Inflammation Ready for Prime Time? |
3302 |
Mechanisms of Neoplasia Underlying Mastocytosis and Hypereosinophilic Syndrome |
3303 |
Development of B Cell Memory: How to Survive in the Germinal Center |
3304 |
Variables in Clinical Trial Design |
3305 |
Pandemic Influenza |
3306 |
Transcription Factors in Allergic Airway Inflammation and Asthma |
3307 |
Stopping the Atopic March |
4301 |
The Interface between Allergy and Autoimmune Disease |
4302 |
Immune and Clinical Factors in Gastrointestinal Disease |
4303 |
HIV/AIDS: An Update for the Allergist/Immunologist |
4304 |
Ethical Safeguards in Clinical Research: What Every Clinician Should Know |
4305 |
Role Of TNF Alpha in Inflammation and Asthma |
4306 |
Novel Approaches to Allergen Immunotherapy |
4307 |
NHLBI Clinical Research Programs: Asthma Exacerbations: What Do Clinical Studies Tell Us About Defining, Predicting and Preventing Them? |
5301 |
The Female Genotype and Immunologic Responses |
5302 |
Food Allergy: New Observations, Diagnostics and Treatments |
5303 |
Recent Advances in Drug Hypersensitivity |
5304 |
Lipid Mediators in Pulmonary Immune Responses and Asthma: New Molecules and New Functions |
5305 |
What Makes an Allergen Allergenic? |
5306 |
NHLBI Clinical Research Programs: Measuring Asthma Impairment and Risk to Determine Response to Therapy: What are the Best Measures? |
5307 |
What is the Optimal Treatment for Virus-Induced Wheezing and Asthma? |
Allied Health Symposia
|
1141 |
Clinical Research (CR) Symposium, Part 1: Biotechnology - From Bench to Bedside |
1151 |
Medical Administrators (MA) Morning Symposia: Risk Management and the Medical Practice |
1511 |
Medical Administrators (MA) Lunch Round Table Symposium |
1651 |
Medical Administrators (MA) Afternoon Symposium: Coding Update for the Allergy Practice |
2041 |
Medical Administrators (MA) Symposium: Staff Recruitment and Retention |
2321 |
Medical Administrators (MA) Morning Symposium: Information Technology - Enhancing Clinical Operations |
State-of-the-Art
|
2501 |
Asthma Immunopathogenesis: A Pathway For Future Therapy |
2502 |
Pathogen Recognition Receptors in Inflammation and Immunity |
2503 |
Gene/Environment Interactions |
2504 |
Role of Food Allergy and Patch Testing in Eosinophilic Esophagitis and Gastroenteritis |
2505 |
Insight Into Disparities in Pediatric Asthma |
2506 |
Advances in OX-40 Ligand Interactions |
2507 |
Obstructive Sleep Apnea: Inflammatory Effects |
Pro/Con Debates
|
3501 |
Strict Allergen Avoidance Speeds Recovery From Food Allergies |
3502 |
Now is the Time to Buy an EMR |
3503 |
Routine Intradermal Skin Testing Offers Benefit in the Diagnosis of Rhinitis and Asthma |
3504 |
IVIG Should Be Used to Treat Hypogammaglobulinemia Without Specific Antibody Deficiency |
3505 |
Pets Prevent Allergic Diseases |
5501 |
LABA are the First Choice Add-on Agent |
5502 |
Chronic Rhinosinusitis Should Be Treated with Antibiotics |
5503 |
Local Reactions Do Not Predict Systemic Reactions |
5504 |
Molds are a Serious Cause of Non-Allergic Health Problems |
5505 |
Home Environmental Control is an Effective Treatment for Allergies |
Interest Section Forums
|
3701 |
ADT Interest Section Forum |
3702 |
BCI Interest Section Forum |
3703 |
EORD Interest Section Forum |
|
3704 |
FADDA Interest Section Forum |
3705 |
HCEDQ Interest Section Forum: Pay for Performance |
3706 |
MAAI Interest Section Forum |
3707 |
RSOD Interest Section Forum |
Courses
|
1101 |
Understanding the Genetic Basis of Asthma and Allergy Susceptibility and Treatment (Part 1) |
1102 |
Developing Clinical Skills to Promote Adherence and Maximize Asthma Outcomes (Part I) |
1103 |
Protective Effects of Infections and Microbial Exposures on Allergic Diseases |
1104 |
Difficult Cases: Part 1 |
1121 |
Basic Aeroallergen Course |
1131 |
NIAID Morning Symposium: Dendritic Cells |
1601 |
Understanding the Genetic Basis of Asthma and Allergy Susceptibility and Treatment (Part 2) |
1602 |
Developing Clinical Skills to Promote Adherence and Maximize Asthma Outcomes (Part 2) |
1603 |
Environmental Effects on Allergic Respiratory Diseases |
1604 |
Difficult Cases: Part 2 |
1605 |
Allergy Diagnostics and Immunotherapy the Nuts and Bolts of an Allergy Practice |
1606 |
Endoscopic Techniques in Treatment of Sinusitis, Both Pre and Post Surgical |
1607 |
Set Up & Operation of a Burkard Pollen/Spore Station |
1608 |
Allergic and Immunologic Skin Disorders |
1621 |
Food Allergy is an International Disease: Regional Differences from Around the World |
1631 |
NIAID Afternoon Symposium: Immunologic Basis of Food Allergy |
1671 |
Launching a Career in Academic Allergy/Immunology |
$10,000 Category
|
Workshops
|
Allied Health Workshops |
1011 |
Clinical Research (CR) Workshop: Site and Investigator Selection |
1012 |
Clinical Research (CR) Workshop: FDA Audits |
1013 |
Clinical Research (CR) Workshop: Ethics in Clinical Research |
1014 |
Clinical Research (CR) Workshop: Is Your Investigative Site in Compliance with Good Clinical Practice |
1501 |
Clinical Research (CR) Workshop: The ABCs of Clinical Research |
1502 |
Clinical Research (CR) Workshop: How Do You Identify, Develop, and Retain Your CRC ? |
1503 |
Clinical Research (CR) Workshop: Pediatric Clinical Trials – Are You Ready? |
1504 |
Clinical Research (CR) Workshop: Are You Prepared for the Future of Clinical Research? |
1505 |
Clinical Research (CR) Workshop: Are You Thinking About Starting Clinical Research? |
$5,000 Category
|
Seminars
|
2511 |
Reimbursement Matters! Use the Perfect CPT Codes |
2512 |
Regulatory T Cells |
2513 |
Mycoplasma, Pneumococcus and Viral Illness…Their Role in Asthma? |
2514 |
What is the Best Way to Follow Asthma Control? |
2515 |
Monoclonal Antibody Therapy of Disease |
2516 |
Hypereosinophillia and Esosinophillia Disease |
2517 |
The Role of Long Acting Beta Agonists in Exercise Induced Bronchospasm |
2518 |
Sick Building Syndrome: Does it Really Exist and How do You Treat It? |
2519 |
Desensitization Protocols for Antibiotics and Other Medications |
2520 |
Chronic Urticaria/Angioedema Update |
2521 |
Newer Treatment Options in CRS |
2522 |
Aspirin-Exacerbated Respiratory Disease: A Model for Eicosanoid Biology in Humans |
2523 |
Stress and Asthma: Immune Mechanisms of Increased Susceptibility to Allergic Sensitization |
2524 |
Nose-Lung Interactions: Does Treating the Nose Ameliorate Asthma? Current Controversies |
2525 |
Specific Aspects of Chronic Sinusitis in Children: Diagnosis, Treatment, Prognosis |
3511 |
Allergen Exposures and Asthma: New Threats and Approaches in the Inner City |
3512 |
Allergens and Global Warming: Is It Really a Problem? |
3513 |
Evaluation of Specific Antibody Responses to Diagnose PID |
3514 |
TSLP: A Key Initiator of the Allergic Response |
3515 |
Controversies in Asthma: The Role of Anti-IgE Therapy
|
3516 |
Airway Remodeling in Asthma |
3517 |
Rhinitis Outcomes Measures in Private Practice |
3518 |
Mechanisms of Neoplasia Affecting Mast Cells and Eosinophils-Pharmacogenetic Approach |
3519 |
Mechanisms of Environmental-Induced Atopy |
3520 |
Refractory Asthma in Adults |
3521 |
Nasal Polyps--What Do We Know and What Do We Do? |
3522 |
Allergern Immunotherapy Vaccine Prescription Writing |
3523 |
Early Intervention in Asthma |
3524 |
Prevention and Natural History of Food Allergy |
3525 |
Allergic Reactions to Vaccines and Vaccine Safety: Avoiding and Managing Adverse Effects |
4821 |
Immunotherapy Practice Parameters--New Guidelines for Practice? |
4822 |
Food Challenges in the Office - When and How |
4823 |
Biogenic Amines in Allergy and Inflammation - New Possibilities for Adjunct Pharmacotherapy |
4824 |
Use of Quality of Life in Clinical Practice to Increase Patient Adherence and Enhance Patient Satisfaction |
4825 |
Formula for Success: Connecting with NIH Program Officers |
Other Available Sessions
|
FIT Programs |
1001 |
2007 Fellows in Training Program |
1002 |
FIT Lunch Symposium |
Asthma Educators |
501 |
AAAAI/Association of Asthma Educators (AAE) National Asthma Educator Certification Review Course |
1021 |
AAAAI/Association of Asthma Educators (AAE) National Asthma Educator Certification Review Course |
Allied Health |
1161 |
Advanced Practice Course For Allied Health Professionals |
